Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation

Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation

US Patent 12433902 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sterically stabilized carrier compositions for treating a mammal2025
Sterically stabilized carrier compositions for treating a mammal2025
Sterically stabilized carrier compositions for treating a mammal2025
Sterically stabilized carrier for aerosol therapeutics, compositions and methods2022
Sterically stabilized carrier for aerosol therapeutics, compositions and methods2014
System for aurally monitoring aeronautical information while in flight2006